Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LRK-4189 Alone and in Combination With Chemotherapy in Solid Tumors
NCT07498725Phase 2Recruiting
- Sponsor
- Larkspur Biosciences
- Start
- Jul 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LRK-4189 in solid tumor, colorectal cancer (CRC), sponsored by Larkspur Biosciences. Started Jul 2026; status: recruiting.
02
Drugs
LRK-4189
03
Conditions
solid tumorcolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07498725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07498725.